{"DataElement":{"publicId":"2698088","version":"2","preferredName":"Hematopoietic Cell Graft Infusion Procedure Route of Administration Type","preferredDefinition":"A description of the route of hematopoietic cell graft (product) infusion.","longName":"HC_INFU_ROUTE_TY","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2698069","version":"2","preferredName":"Hematopoietic Cell Graft  Infusion Procedure Route of Administration","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body._A method of putting fluids, including drugs, into the bloodstream. Also called intravenous infusion._Designation of the part of the body through which or into which, or the way in which, the medicinal product is intended to be introduced. In some cases a medicinal product can be intended for more than one route and/or method of administration.","longName":"HC_INFU_ROUTE","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2779420","version":"1","preferredName":"Hematopoietic Stem Cell Graft Infusion Procedure","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.):Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body.:A method of putting fluids, including drugs, into the bloodstream. Also called intravenous infusion.","longName":"C12551:C12981:C15388","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Stem Cell","conceptCode":"C12551","definition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Graft","conceptCode":"C12981","definition":"Tissue or organ transplanted from a donor to a recipient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Infusion Procedure","conceptCode":"C15388","definition":"Any form of treatment that is introduced into the body via a blood vessel, a muscle, or the spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55EF6012-D12C-09AE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-02","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-09-02","modifiedBy":"ONEDATA","dateModified":"2008-09-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2437708","version":"1","preferredName":"Route of Administration","preferredDefinition":"The course by which a substance was administered in order to reach the site of action in the body.","longName":"C38114","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Route of Administration","conceptCode":"C38114","definition":"Designation of the part of the body through which or into which, or the way in which, the medicinal product is intended to be introduced. In some cases a medicinal product can be intended for more than one route and/or method of administration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07F9A295-F47D-5DFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-15","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-12-15","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8C09F6D-5CAA-5259-E040-BB89AD43093F","latestVersionIndicator":"Yes","beginDate":"2007-11-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-03-25","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2697793","version":"1","preferredName":"Route of Administration Type","preferredDefinition":"Designation of the part of the body through which or into which, or the way in which, the medicinal product is intended to be introduced. In some cases a medicinal product can be intended for more than one route and/or method of administration._Type; a subdivision of a particular kind of thing.","longName":"ROUTE_TY","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other route of infusion","valueDescription":"Other Route of Administration","ValueMeaning":{"publicId":"2577939","version":"1","preferredName":"Other Route of Administration","longName":"2577939","preferredDefinition":"Not otherwise specified.: The course by which a substance was administered in order to reach the site of action in the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Route of Administration","conceptCode":"C38114","definition":"Designation of the part of the body through which or into which, or the way in which, the medicinal product is intended to be introduced. In some cases a medicinal product can be intended for more than one route and/or method of administration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FD80-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"ZHANGW","dateModified":"2008-10-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"597649F3-2F5E-1C08-E044-0003BA3F9857","beginDate":"2008-10-17","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-10-17","modifiedBy":"ZHANGW","dateModified":"2008-10-17","deletedIndicator":"No"},{"value":"Intraperitoneal","valueDescription":"Intraperitoneal Route of Administration","ValueMeaning":{"publicId":"2578020","version":"1","preferredName":"Intraperitoneal Route of Administration","longName":"2578020","preferredDefinition":"Administration within the peritoneal cavity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraperitoneal Route of Administration","conceptCode":"C38258","definition":"Administration of a drug via injection or infusion of a substance into the peritoneum, where it is absorbed by the lining.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDD1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"597649F3-2F73-1C08-E044-0003BA3F9857","beginDate":"2008-10-17","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-10-17","modifiedBy":"ZHANGW","dateModified":"2008-10-17","deletedIndicator":"No"},{"value":"Intramedullary","valueDescription":"Intramedullary Route of Administration","ValueMeaning":{"publicId":"2578018","version":"1","preferredName":"Intramedullary Route of Administration","longName":"2578018","preferredDefinition":"Administration within the marrow cavity of a bone.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intramedullary Route of Administration","conceptCode":"C38253","definition":"Administration of a drug within the marrow cavity of a bone. The essential premise for intraosseous administration is a functioning medullary cavity. The route is considered reasonably safe and permits rapid achievement of satisfactory plasma concentrations of therapeutic agent. The route is used for blood transfusion or fluid therapy when other routes are awkward, as in neonates.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDCF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"597649F3-2F88-1C08-E044-0003BA3F9857","beginDate":"2008-10-17","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-10-17","modifiedBy":"ZHANGW","dateModified":"2008-10-17","deletedIndicator":"No"},{"value":"Intravenous","valueDescription":"Intravenous Route of Administration","ValueMeaning":{"publicId":"2578035","version":"1","preferredName":"Intravenous Route of Administration","longName":"2578035","preferredDefinition":"Administration within or into a vein or veins.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intravenous Route of Administration","conceptCode":"C38276","definition":"Administration of a drug within or into a vein or veins. Introduction of the drug directly into venous circulation results in 100% bioavailability due to an absence of the absorption phase, provides a precise and continuous mode of drug therapy, especially for drugs with a narrow therapeutic index.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDE0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"597649F3-2F9D-1C08-E044-0003BA3F9857","beginDate":"2008-10-17","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-10-17","modifiedBy":"ZHANGW","dateModified":"2008-10-17","deletedIndicator":"No"},{"value":"Intrathecal","valueDescription":"Intrathecal Route of Administration","ValueMeaning":{"publicId":"3629940","version":"1","preferredName":"Intrathecal Route of Administration","longName":"3629940","preferredDefinition":"Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrathecal Route of Administration","conceptCode":"C38267","definition":"Administration of drugs directly into spinal subarachnoid space in the cerebrospinal fluid, at any level of the cerebrospinal axis, including injection into the cerebral ventricles, in order to bypass the blood-brain barrier and achieve local, rapid effects on the meninges or cerebrospinal axis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF057A49-8411-F346-E040-BB89AD432CDD","latestVersionIndicator":"Yes","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2B5AEB48-5CA4-3086-E050-BB89AD4334C2","beginDate":"2016-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-09","modifiedBy":"ONEDATA","dateModified":"2016-02-09","deletedIndicator":"No"},{"value":"Intramuscular","valueDescription":"Intramuscular Route of Administration","ValueMeaning":{"publicId":"2578009","version":"1","preferredName":"Intramuscular Route of Administration","longName":"2578009","preferredDefinition":"Administration within a muscle.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intramuscular Route of Administration","conceptCode":"C28161","definition":"Intramuscular injection is a route of drug administration via injection into muscle tissue. Aqueous or oleaginous solutions and emulsions or suspensions may be administered. Absorption rates, delay in availability of the drug to the systemic circulation, and duration of effect are perfusion-limited, depend on molecular size of the agent, volume, and osmolarity of the drug solution, fat content of the injection site, and patient physical activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDC6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2B5AEB48-5CAE-3086-E050-BB89AD4334C2","beginDate":"2016-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-09","modifiedBy":"ONEDATA","dateModified":"2016-02-09","deletedIndicator":"No"},{"value":"Intra arterial","valueDescription":"Intraarterial Route of Administration","ValueMeaning":{"publicId":"2578037","version":"1","preferredName":"Intraarterial Route of Administration","longName":"2578037","preferredDefinition":"Administration within an artery or arteries.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraarterial Route of Administration","conceptCode":"C38222","definition":"The administration of a substance directly into an artery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDE2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2B5AEB48-5CC2-3086-E050-BB89AD4334C2","beginDate":"2016-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-09","modifiedBy":"ONEDATA","dateModified":"2016-02-09","deletedIndicator":"No"},{"value":"Locally in the tissue","valueDescription":"Locally Tissue","ValueMeaning":{"publicId":"5119431","version":"1","preferredName":"Locally Tissue","longName":"5119431","preferredDefinition":"To a restricted area (of the body).: An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Locally","conceptCode":"C41065","definition":"To a restricted area (of the body).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tissue","conceptCode":"C12801","definition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2B5AEB48-5CD1-3086-E050-BB89AD4334C2","latestVersionIndicator":"Yes","beginDate":"2016-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2B5AEB48-5CEA-3086-E050-BB89AD4334C2","beginDate":"2016-02-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-09","modifiedBy":"ONEDATA","dateModified":"2016-02-09","deletedIndicator":"No"},{"value":"Intraorgan","valueDescription":"Within Organ","ValueMeaning":{"publicId":"5121871","version":"1","preferredName":"Within Organ","longName":"5121871","preferredDefinition":"On the inside; contained in.: A unique macroscopic (gross) anatomic structure that performs specific functions.  It is composed of various tissues.  An organ is part of an anatomic system or a body region.  Representative examples include the heart, lung, liver, spleen, and uterus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Within","conceptCode":"C25282","definition":"On the inside; contained in.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Organ","conceptCode":"C13018","definition":"A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues.  An organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2B8226A5-682D-78B7-E050-BB89AD433B58","latestVersionIndicator":"Yes","beginDate":"2016-02-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2B8226A5-6846-78B7-E050-BB89AD433B58","beginDate":"2016-02-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-11","modifiedBy":"ONEDATA","dateModified":"2016-02-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2486825","version":"1","preferredName":"Route of Administration Type","preferredDefinition":"The course by which a substance was administered in order to reach the site of action in the body.:Type; a subdivision of a particular kind of thing.","longName":"C38114:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Route of Administration","conceptCode":"C38114","definition":"Designation of the part of the body through which or into which, or the way in which, the medicinal product is intended to be introduced. In some cases a medicinal product can be intended for more than one route and/or method of administration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"16358911-63C0-2575-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-14","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-14","modifiedBy":"ONEDATA","dateModified":"2006-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F616175-4FA7-15F8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-20","endDate":null,"createdBy":"ZHANGW","dateCreated":"2007-11-20","modifiedBy":"KUMMEROA","dateModified":"2016-02-11","changeDescription":"Added 4 PVs for 4006. AK 2/9/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"Hematopoietic Stem Cell Graft  Infusion Procedure Route of Administration Type","type":"System-Generated","context":"NHLBI"},{"name":"PerformedSubstanceAdministration:routeOfAdministration","type":"HCT_BRIDG","context":"NHLBI"},{"name":"inf_prod_infuse_prod_infused_route","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Specify the route of product","type":"Preferred Question Text","description":"Specify the route of product infusion:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping for CDE:2698088","type":"BRIDG Mapping Path","description":"PerformedSubstanceAdministration.routeOfAdministration WHERE PerformedSubstanceAdmininstration > DefinedSubstanceAdministration.nameCode = \"Administer Hematopoetic Stem cell Product {Transplantation}\"","url":null,"context":"NHLBI"},{"name":"Specify the route of product infusion","type":"Application Standard Question Text","description":"Specify the route of product infusion","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D8C2458A-BFCD-A416-E040-BB89AD437458","latestVersionIndicator":"Yes","beginDate":"2007-11-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-03-25","modifiedBy":"ALEYR","dateModified":"2019-04-07","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}